Short-course Antimicrobial Therapy in Sepsis

• Status: Recruiting
• Trial end date: 2021-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the effect of a short course antimicrobial therapy (5-days) versus a 10-days therapy on sepsis-related organ dysfunction.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ospedale Santa Maria delle Croci
• Treatments: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular

Criteria

Inclusion Criteria:

• Patients who received antibiotics for presumed infection

Exclusion Criteria:

• Prolonged therapy (eg, endocarditis)

• Severe immunosuppression

• Severe infections (due to viruses, parasites, or Mycobacterium tuberculosis)

• Patients previously infected or colonized with multidrug resistant pathogens and moribund patients.